CXCL12/SDF-1 antibody 17402-1-AP from Proteintech Group Inc

Product Specs
ItemCXCL12/SDF-1 antibody
CompanyProteintech Group Inc
Price Pricing Info Supplier Page View Company Product Page
Catalog Number17402-1-AP
Quantity20ul
ApplicationsWB, IHC, IF, FC, ELISA
Conjugate/TagUnconjugated
FormatPBS with 0.02% sodium azide and 50% glycerol pH 7.3
ReactivityHuman, Mouse
IsotypeIgG
HostRabbit
Antibody Typeprimary antibodies
ClonalityPolyclonal
PurityAntigen affinity purification
ImmunogenRecombinant protein
NCBI Full Gene NameC-X-C motif chemokine ligand 12
NCBI Gene AliasesIRH, PBSF, SCYB12, SDF1, TLSF, TPAR1
Research AreaBinding Proteins, Cytoskeleton/Scaffold Proteins, Growth Factor/Cytokine/Hormone, Immunology, Membrane Proteins, Plasma/Serum, Signal transduction
TargetCXCL12/SDF-1

Specifications/Features

20ul available

Add to Compare List

Proteintech Group Inc

5500 Pearl Street, Suite 400

Rosemont,, Illinois 60018

United States

Phone: 1-888-478-4522

Email: proteintech@ptglab.com

Company Profile

Website: http://www.ptglab.com

(1) Single-cell analysis reveals immune cellular components in odontogenic keratocystsOral diseasesNovember 1, 2023Man QW, Li RF, Liu JF, Zhao Y, Liu B.

(2) Tibial cortex transverse transport potentiates diabetic wound healing via activation of SDF-1/CXCR4 signalingPeerJSeptember 15, 2023Shuanji Ou, Xiaodong Wu, Yang Yang, Changliang Xia, Wei Zhang, Yudun Qu, Jiaxuan Li, Bo Chen, Lilin Zhu, Changpeng Xu, et al.1:200; Santa Cruz Biotechnology), anti-CXCR4 (ab124824; Abcam, Cambridge, MA, USA, 1:200), anti-SDF-1 (17402-1-AP; Proteintech, Rosemont, IL, USA, 1:500), Goat anti-rat-IgG H&L (FITC, ab6840, 1:1,000; FITC, Abcam),

(3) [MiR-30e-5p overexpression promotes proliferation and migration of colorectal cancer cells by activating the CXCL12 axis via downregulating PTEN]Nan fang yi ke da xue xue bao = Journal of Southern Medical UniversityJuly 20, 2023Wei K, Shi J, Xiao Y, Wang W, Yang Q, Chen C.

(4) Herpetin Promotes Bone Marrow Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Acute Liver Injury in MiceMolecules (Basel, Switzerland)May 1, 2023Ding Y, Tan R, Gu J, Gong P.

(5) 3D bioprinted autologous bone particle scaffolds for cranioplasty promote bone regeneration with both implanted and native BMSCsBiofabricationMarch 14, 2023Huan Y, Zhou D, Wu X, He X, Chen H, Li S, Jia B, Dou Y, Fei X, Wu S, et al.

(6) Age-related liver endothelial zonation triggers steatohepatitis by inactivating pericentral endothelium-derived C-kitNat AgingMarch 1, 2023Duan JL, Liu JJ, Ruan B, Ding J, Fang ZQ, Xu H, Song P, Xu C, Li ZW, Du W, et al.

(7) Prognostic Value of CXCL12 in Non-Small Cell Lung Cancer Patients Undergoing Tumor ResectionPharmaceuticals (Basel, Switzerland)February 7, 2023Kogue Y, Kobayashi H, Nakamura Y, Takano T, Furuta C, Kawano O, Yasuma T, Nishimura T, D'Alessandro-Gabazza CN, Fujimoto H, et al.

(8) Saxagliptin alleviates erectile dysfunction through increasing stromal cell-derived factor-1 in diabetes mellitusAndrologyFebruary 1, 2023Sun T, Xu W, Wang J, Wang T, Wang S, Liu K, Liu J.

(9) Multi-omics reveals Dengzhan Shengmai formulation ameliorates cognitive impairments in D-galactose-induced aging mouse model by regulating CXCL12/CXCR4 and gut microbiotaFrontiers in pharmacologyJanuary 1, 2023Hou JY, Xu H, Cao GZ, Tian LL, Wang LH, Zhu NQ, Zhang JJ, Yang HJ.

(10) Matrix vesicles promote bone repair after a femoral bone defect in micePloS oneJanuary 1, 2023Mizukami Y, Kawao N, Takafuji Y, Ohira T, Okada K, Jo JI, Tabata Y, Kaji H.

(11) Growth arrest-specific protein 2 (GAS2) interacts with CXCR4 to promote T-cell leukemogenesis partially via c-MYCMolecular oncologyOctober 1, 2022Ma W, Wan Y, Zhang J, Yao J, Wang Y, Lu J, Liu H, Huang X, Zhang X, Zhou H, et al.

(12) miR-126 downregulates CXCL12 expression in intestinal epithelial cells to suppress the recruitment and function of macrophages and tumorigenesis in a murine model of colitis-associated colorectal cancerMolecular oncologyOctober 1, 2022Wu S, Yuan W, Luo W, Nie K, Wu X, Meng X, Shen Z, Wang X.sections from mice. The deparaffinised sections were incubated with a CXCL12 polyclonal antibody (Cat. no. 17402‐1‐AP; Proteintech, Rosemont, IL, USA; 1 : 200), a CD68 polyclonal antibody (Cat. no. 28058‐1‐AP; Proteintech;

(13) Tumor promoting effect of circ_002172 associates with induced immune escape in breast cancer via the miR-296-5p/CXCL12 axisInternational immunopharmacologyMay 1, 2022Li P, Ren X, Zheng Y, Sun J, Ye G.

(14) SDF-1 inhibits the dedifferentiation of islet β cells in hyperglycaemia by up-regulating FoxO1 via binding to CXCR4Journal of cellular and molecular medicineFebruary 1, 2022Chen XY, Shi YX, Huang YP, Ding M, Shen QL, Li CJ, Lin JN.purchased from GeneCopoeia (item number: EX‐Mm05138‐M98). 2.3 Reagents 2.3.1 The main antibodies SDF‐1 (17402–1‐AP, Proteintech, China, RRID: AB_2878404). SOX9 (ab185966, Abcam, UK, RRID: AB_2728660). NGN3 (ab216885,

(15) miR-1273h-5p suppresses CXCL12 expression and inhibits gastric cancer cell invasion and metastasisOpen medicine (Warsaw, Poland)January 1, 2022Wang YC, Lu S, Zhou XJ, Yang L, Liu P, Zhang L, Hu Y, Dong XZ.3 h at room temperature, the membranes were incubated with primary antibodies (CXCL12, Proteintech, 17402-1-AP; β-tubulin, Immunoway, YM3030; GAPDH, Immunoway, YM3029) at 4°C overnight followed by incubation with

(16) C-X-C-Chemokine-Receptor-Type-4 Inhibitor AMD3100 Attenuates Pulmonary Inflammation and Fibrosis in Silicotic MiceJournal of inflammation researchJanuary 1, 2022Sun Q, Tao X, Li B, Cao H, Chen H, Zou Y, Tao H, Mu M, Wang W, Xu K.staining, we used the following primary antibodies: collagen type I (14695-1-AP, Proteintech), CXCL12 (17402-1-AP, Proteintech), α-smooth muscle actin (α-SMA, ab124964, Abcam), MPO (ab9535, Abcam), CXCR4 (ab1670, Abcam),

(17) Dihydroartemisinin attenuates osteoclast formation and bone resorption via inhibiting the NF‑κB, MAPK and NFATc1 signaling pathways and alleviates osteoarthritisInternational journal of molecular medicineJanuary 1, 2022Ding D, Yan J, Feng G, Zhou Y, Ma L, Jin Q.4°C with primary antibodies (all diluted 1:100) against RANKL (cat. no. 23408-1-AP), CXCL12 (cat. no. 17402-1-AP; both from ProteinTech Group Inc.) and NFATc1 (cat. no. ab264530; Abcam). After washing three times

(18) NLRP3 downregulation enhances engraftment and functionality of adipose-derived stem cells to alleviate erectile dysfunction in diabetic ratsFrontiers in endocrinologyJanuary 1, 2022Luo C, Peng Y, Zhou X, Fan J, Chen W, Zhang H, Wei A.primary antibodies for cytokines included anti-VEGFA (1:1000; ab214424, Abcam), anti-SDF-1 (1:500; 17402-1-AP, Proteintech), and anti-FGF2 (1:1000; DF6038, Affinity). Furthermore, ASC (apoptosis-associated speckled

(19) Zoledronic acid generates a spatiotemporal effect to attenuate osteoarthritis by inhibiting potential Wnt5a-associated abnormal subchondral bone resorptionPloS oneJanuary 1, 2022Ding D, Wang L, Yan J, Zhou Y, Feng G, Ma L, Yang Y, Pei X, Jin Q.incubated overnight at 4°C with primary antibodies (all diluted 1:100) against Wnt5a (55184-1-AP), CXCL12 (17402-1-AP; both from Proteintech Group Inc., Rosemont, IL, USA), and NFATc1 (ab264530; Abcam, Cambridge, UK).

(20) The protective mechanism of Klotho gene-modified bone marrow mesenchymal stem cells on acute kidney injury induced by rhabdomyolysisRegenerative therapyDecember 1, 2021Ni W, Zhang Y, Yin Z.

Be the First to Write a Review!

CXCL12/SDF-1 antibody

CXCL12/SDF-1 antibody

CXCL12/SDF-1 antibody from Proteintech Group Inc

Description

Specifications/Features

Proteintech Group Inc

Citations (39)

Reviews

CXCL12/SDF-1 antibody from Proteintech Group Inc

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map